The AP-1 family member FOS blocks transcriptional activity of the nuclear receptor steroidogenic factor 1

Journal of Cell Science

Volumn 123, Issue 22, 2010, Pages 3956-3965

  Sirianni, Rosa ^a   Nogueira, Edson ^b   Bassett, Mary H ^c   Carr, Bruce R ^c   Suzuki, Takashi ^d   Pezzi, Vincenzo ^a   Andò, Sebastiano ^a   Rainey, William E ^b  

^a UNIVERSITY OF CALABRIA   (Italy)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adrenal; AP 1; CYP17; SF 1

Indexed keywords

ANGIOTENSIN II; CELL NUCLEUS RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYTOCHROME P450 17; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NUCLEAR RECEPTOR STEROIDOGENIC FACTOR 1; PROTEIN FOS; PROTEIN KINASE C; STEROID RECEPTOR COACTIVATOR 1; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM SIGNALING; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; REGULATORY MECHANISM;

ADRENAL GLANDS; CALCIUM SIGNALING; CELL CULTURE TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; NFI TRANSCRIPTION FACTORS; PROTEIN KINASE C; STEROID 17-ALPHA-HYDROXYLASE; STEROIDOGENIC FACTOR 1; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION;

EID: 78649740261     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.055806     Document Type: Article

References (57)

1. Bain, D. L., Heneghan, A. F., Connaghan-Jones, K. D. and Miura, M. T. (2007). Nuclear receptor structure: implications for function. Annu. Rev. Physiol. 69, 201-220.
2. Beshay, V. E., Havelock, J. C., Sirianni, R., Ye, P., Suzuki, T., Rainey, W. E. and Carr, B. R. (2007). The mechanism for protein kinase C inhibition of androgen production and 17alpha-hydroxylase expression in a theca cell tumor model. J. Clin. Endocrinol. Metab. 92, 4802-4809.
3. Bird, I. M., Magness, R. R., Mason, J. I. and Rainey, W. E. (1992). Angiotensin-II acts via the type 1 receptor to inhibit 17 alpha-hydroxylase cytochrome P450 expression in ovine adrenocortical cells. Endocrinology 130, 3113-3121.
4. Bird, I. M., Hanley, N. A., Word, R. A., Mathis, J. M., McCarthy, J. L., Mason, J. I. and Rainey, W. E. (1993). Human NCI-H295 adrenocortical carcinoma cells: a model for angiotensin-II-responsive aldosterone secretion. Endocrinology 133, 1555-1561.
5. Bird, I. M., Pasquarette, M. M., Rainey, W. E. and Mason, J. I. (1996). Differential control of 17 alpha-hydroxylase and 3 beta-hydroxysteroid dehydrogenase expression in human adrenocortical H295R cells. J. Clin. Endocrinol. Metab. 81, 2171-2178.
6. Bird, I. M., Mason, J. I. and Rainey, W. E. (1998). Battle of the kinases: integration of adrenal responses to cAMP, DG and Ca2+ at the level of steroidogenic cytochromes P450 and 3betaHSD expression in H295R cells. Endocr. Res. 24, 345-354.
7. Brentano, S. T., Picado-Leonard, J., Mellon, S. H., Moore, C. C. and Miller, W. L. (1990). Tissue-specific, cyclic adenosine 3′,5′- monophosphate-induced, and phorbol ester-repressed transcription from the human P450c17 promoter in mouse cells. Mol. Endocrinol. 4, 1972-1979.
8. Cacace, A. M., Ueffing, M., Philipp, A., Han, E. K., Kolch, W. and Weinstein, I. B. (1996). PKC epsilon functions as an oncogene by enhancing activation of the Raf kinase. Oncogene 13, 2517-2526.
9. Cai, H., Smola, U., Wixler, V., Eisenmann-Tappe, I., Diaz-Meco, M. T., Moscat, J., Rapp, U. and Cooper, G. M. (1997). Role of diacylglycerol-regulated protein kinase C isotypes in growth factor activation of the Raf-1 protein kinase. Mol. Cell. Biol. 17, 732-741.
10. Chen, R. H., Abate, C. and Blenis, J. (1993). Phosphorylation of the c-FOS transrepression domain by mitogen-activated protein kinase and 90-kDa ribosomal S6 kinase. Proc. Natl. Acad. Sci. USA 90, 10952-10956.
11. Chen, R., Juo, P., Curran, T. and Blenis, J. (1996). Phosphorylation of c-FOS at the C-terminus enhances its transforming activity. Oncogene 12, 1493-1502.
12. Cherradi, N., Pardo, B., Greenberg, A. S., Kraemer, F. B. and Capponi, A. M. (2003). Angiotensin II activates cholesterol ester hydrolase in bovine adrenal glomerulosa cells through phosphorylation mediated by p42/p44 mitogen-activated protein kinase. Endocrinology 144, 4905-4915.
13. Clark, A. J., Balla, T., Jones, M. R. and Catt, K. J. (1992). Stimulation of early gene expression by angiotensin II in bovine adrenal glomerulosa cells: roles of calcium and protein kinase C. Mol. Endocrinol. 6, 1889-1898.
14. Crawford, P. A., Polish, J. A., Ganpule, G. and Sadovsky, Y. (1997). The activation function-2 hexamer of steroidogenic factor-1 is required, but not sufficient for potentiation by SRC-1. Mol. Endocrinol. 11, 1626-1635.
15. Curran, T. and Franza, B. R., Jr (1988). FOS and JUN: the AP-1 connection. Cell 55, 395-397.
16. Dammer, E. B., Leon, A. and Sewer, M. B. (2007). Coregulator exchange and sphingosine-sensitive cooperativity of steroidogenic factor-1, general control nonderepressed 5, p54, and p160 coactivators regulate cyclic adenosine 3′,5′-monophosphate-dependent cytochrome P450c17 transcription rate. Mol. Endocrinol. 21, 415-438.
17. Hanley, N. A., Rainey, W. E., Wilson, D. I., Ball, S. G. and Parker, K. L. (2001). Expression profiles of SF-1, DAX1, and CYP17 in the human fetal adrenal gland: potential interactions in gene regulation. Mol. Endocrinol. 15, 57-68.
18. Ito, M., Yu, R. N. and Jameson, J. L. (1998). Steroidogenic factor-1 contains a carboxy-terminal transcriptional activation domain that interacts with steroid receptor coactivator-1. Mol. Endocrinol. 12, 290-301.
19. Kerppola, T. K. and Curran, T. (1993). Selective DNA bending by a variety of bZIP proteins. Mol. Cell. Biol. 13, 5479-5489.
20. Kerppola, T. K. and Curran, T. (1997). The transcription activation domains of FOS and JUN induce DNA bending through electrostatic interactions. EMBO J. 16, 2907-2916.
21. LeHoux, J. G. and Ducharme, L. (1995). In vivo effects of adrenocorticotropin on c-jun, jun-B, c-fos and fos-B in rat adrenal. Endocr. Res. 21, 267-274.
22. Liu, Z. and Simpson, E. R. (1997). Steroidogenic factor 1 (SF-1) and SP1 are required for regulation of bovine CYP11A gene expression in bovine luteal cells and adrenal Y1 cells. Mol. Endocrinol. 11, 127-137.
23. Lund, J., Borud, B., Mellgren, G., Aesoy, R., Hoang, T., Jacob, A. L. and Bakke, M. (2002). Differential regulation of SF-1-cofactor interactions. Endocr. Res. 28, 505-513.
24. Manna, P. R., Eubank, D. W. and Stocco, D. M. (2004). Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene. Mol. Endocrinol. 18, 558-573.
25. Mason, J. I., Carr, B. R. and Rainey, W. E. (1986). The action of phorbol ester on steroidogenesis in cultured human fetal adrenal cells. Endocr. Res 12, 447-467.
26. Mazzocchi, G., Malendowicz, L. K., Gottardo, G., Rebuffat, P. and Nussdorfer, G. G. (1997). Angiotensin-II stimulates DNA synthesis in rat adrenal zona glomerulosa cells: receptor subtypes involved and possible signal transduction mechanism. Endocr. Res. 23, 191-203.
27. McAllister, J. M. and Hornsby, P. J. (1988). Dual regulation of 3 beta-hydroxysteroid dehydrogenase, 17 alpha-hydroxylase, and dehydroepiandrosterone sulfotransferase by adenosine 3′,5′- monophosphate and activators of protein kinase C in cultured human adrenocortical cells. Endocrinology 122, 2012-2018.
28. McGee, E. A., Sawetawan, C., Bird, I., Rainey, W. E. and Carr, B. R. (1996). The effect of insulin and insulin-like growth factors on the expression of steroidogenic enzymes in a human ovarian thecal-like tumor cell model. Fertil. Steril. 65, 87-93.
29. Monje, P., Marinissen, M. J. and Gutkind, J. S. (2003). Phosphorylation of the carboxyl-terminal transactivation domain of c-FOS by extracellular signal-regulated kinase mediates the transcriptional activation of AP-1 and cellular transformation induced by platelet-derived growth factor. Mol. Cell. Biol. 23, 7030-7043.
30. Monte, D., DeWitte, F. and Hum, D. W. (1998). Regulation of the human P450scc gene by steroidogenic factor 1 is mediated by CBP/p300. J. Biol. Chem. 273, 4585-4591.
31. Naseeruddin, S. A. and Hornsby, P. J. (1990). Regulation of 11 beta- and 17 alpha-hydroxylases in cultured bovine adrenocortical cells: 3′,5′-cyclic adenosine monophosphate, insulin-like growth factor-I, and activators of protein kinase C. Endocrinology 127, 1673-1681.
32. Nogueira, E. F., Vargas, C. A., Otis, M., Gallo-Payet, N., Bollag, W. B. and Rainey, W. E. (2007). Angiotensin-II acute regulation of rapid response genes in human, bovine, and rat adrenocortical cells. J. Mol. Endocrinol. 39, 365-374.
33. Ogishima, T., Suzuki, H., Hata, J., Mitani, F. and Ishimura, Y. (1992). Zone-specific expression of aldosterone synthase cytochrome P-450 and cytochrome P-45011 beta in rat adrenal cortex: histochemical basis for the functional zonation. Endocrinology 130, 2971-2977.
34. Onate, S. A., Tsai, S. Y., Tsai, M. J. and O'Malley, B. W. (1995). Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270, 1354-1357.
35. Otis, M., Campbell, S., Payet, M. D. and Gallo-Payet, N. (2005). Angiotensin II stimulates protein synthesis and inhibits proliferation in primary cultures of rat adrenal glomerulosa cells. Endocrinology 146, 633-642.
36. Rainey, W. E. (1999). Adrenal zonation: clues from 11beta-hydroxylase and aldosterone synthase. Mol. Cell Endocrinol. 151, 151-160.
37. Rainey, W. E., Naville, D. and Mason, J. I. (1991a). Regulation of 3 beta-hydroxysteroid dehydrogenase in adrenocortical cells: effects of angiotensin-II and transforming growth factor beta. Endocr. Res. 17, 281-296.
38. Rainey, W. E., Oka, K., Magness, R. R. and Mason, J. I. (1991b). Ovine fetal adrenal synthesis of cortisol: regulation by adrenocorticotropin, angiotensin II and transforming growth factor-beta. Endocrinology 129, 1784-1790.
39. Rainey, W. E., Bird, I. M. and Mason, J. I. (1992). Angiotensin II-directed glomerulosa cell function in fetal adrenal cells. J. Steroid. Biochem. Mol. Biol. 43, 847-854.
40. Rainey, W. E., Bird, I. M. and Mason, J. I. (1994). The NCI-H295 cell line: a pluripotent model for human adrenocortical studies. Mol. Cell. Endocrinol. 100, 45-50.
41. Rincon Garriz, J. M., Suarez, C. and Capponi, A. M. (2009). c-FOS mediates angiotensin II-induced aldosterone production and protein synthesis in bovine adrenal glomerulosa cells. Endocrinology 150, 1294-1302.
42. Romero, D. G., Rilli, S., Plonczynski, M. W., Yanes, L. L., Zhou, M. Y., Gomez-Sanchez, E. P. and Gomez-Sanchez, C. E. (2007). Adrenal transcription regulatory genes modulated by angiotensin II and their role in steroidogenesis. Physiol. Genomics 30, 26-34.
43. Roux, P. P. and Blenis, J. (2004). ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 68, 320-344.
44. Ryseck, R. P. and Bravo, R. (1991). c-JUN, JUN B, and JUN D differ in their binding affinities to AP-1 and CRE consensus sequences: effect of FOS proteins. Oncogene 6, 533-542.
45. Sasano, H., Mason, J. I. and Sasano, N. (1989). Immunohistochemical study of cytochrome P-45017 alpha in human adrenocortical disorders. Hum. Pathol. 20, 113-117.
46. Sewer, M. B. and Waterman, M. R. (2003). cAMP-dependent protein kinase enhances CYP17 transcription via MKP-1 activation in H295R human adrenocortical cells. J. Biol. Chem. 278, 8106-8111.
47. Sewer, M. B. and Jagarlapudi, S. (2009). Complex assembly on the human CYP17 promoter. Mol. Cell. Endocrinol. 300, 109-114.
48. Sewer, M. B., Nguyen, V. Q., Huang, C. J., Tucker, P. W., Kagawa, N. and Waterman, M. R. (2002). Transcriptional activation of human CYP17 in H295R adrenocortical cells depends on complex formation among p54(nrb)/NonO, protein-associated splicing factor, and SF-1, a complex that also participates in repression of transcription. Endocrinology 143, 1280-1290.
49. Shea-Eaton, W., Sandhoff, T. W., Lopez, D., Hales, D. B. and McLean, M. P. (2002). Transcriptional repression of the rat steroidogenic acute regulatory (StAR) protein gene by the AP-1 family member c-FOS. Mol. Cell. Endocrinol. 188, 161-170.
50. Sirianni, R., Rehman, K. S., Carr, B. R., Parker, C. R., Jr and Rainey, W. E. (2005). Corticotropin-releasing hormone directly stimulates cortisol and the cortisol biosynthetic pathway in human fetal adrenal cells. J. Clin. Endocrinol. Metab. 90, 279-285.
51. Suzuki, T., Sasano, H., Takeyama, J., Kaneko, C., Freije, W. A., Carr, B. R. and Rainey, W. E. (2000). Developmental changes in steroidogenic enzymes in human postnatal adrenal cortex: immunohistochemical studies. Clin. Endocrinol. 53, 739-747.
52. Tian, Y., Smith, R. D., Balla, T. and Catt, K. J. (1998). Angiotensin II activates mitogen-activated protein kinase via protein kinase C and Ras/Raf-1 kinase in bovine adrenal glomerulosa cells. Endocrinology 139, 1801-1809.
53. Viard, I., Jaillard, C., Ouali, R. and Saez, J. M. (1992). Angiotensin-II-induced expression of proto-oncogene (c-fos, jun-B and c-jun) mRNA in bovine adrenocortical fasciculata cells (BAC) is mediated by AT-1 receptors. FEBS Lett. 313, 43-46.
54. Vinciguerra, M., Vivacqua, A., Fasanella, G., Gallo, A., Cuozzo, C., Morano, A., Maggiolini, M. and Musti, A. M. (2004). Differential phosphorylation of c-JUN and JUND in response to the epidermal growth factor is determined by the structure of MAPK targeting sequences. J. Biol. Chem. 279, 9634-9641.
55. Watanabe, G., Lee, R. J., Albanese, C., Rainey, W. E., Batlle, D. and Pestell, R. G. (1996). Angiotensin II activation of cyclin D1-dependent kinase activity. J. Biol. Chem. 271, 22570-22577.
56. Watanabe, G., Pena, P., Albanese, C., Wilsbacher, L. D., Young, J. B. and Pestell, R. G. (1997). Adrenocorticotropin induction of stress-activated protein kinase in the adrenal cortex in vivo. J. Biol. Chem. 272, 20063-20069.
57. Wong, M., Ramayya, M. S., Chrousos, G. P., Driggers, P. H. and Parker, K. L. (1996). Cloning and sequence analysis of the human gene encoding steroidogenic factor 1. J. Mol. Endocrinol. 17, 139-147.